HLA II genes distribution in Epstein–Barr virus-associated nasopharyngeal carcinoma and other tumors of the oral cavity patients in Russia
Background. It has been proved that for the nasopharyngeal carcinoma (NPC) the etiological agent is the Epstein–Barr virus (EBV). Being an ubiquitous infection, EBV, under certain conditions, is able to display its oncogenic potential. Among a wide range of tumors associated with EBV, the NPC occupi...
Main Authors: | N. B. Senyuta, M. N. Boldyreva, E. V. Goncharova, D. M. Maximovich, L. N. Shcherbak, T. E. Dushenkina, V. E. Gurtsevitch |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2018-05-01
|
Series: | Uspehi Molekulârnoj Onkologii |
Subjects: | |
Online Access: | https://umo.abvpress.ru/jour/article/view/135 |
Similar Items
-
Characterization of aberrantly expressed microRNAs in Epstein-Barr virus-associated nasopharyngeal carcinoma.
Published: (2013) -
Epstein-barr virus serology in the management of recurrent nasopharyngeal carcinoma
by: Chan, Yu-wai, et al.
Published: (2015) -
EPSTEIN–BARR VIRUS IN THE POPULATION OF TWO GEOGRAPHICALLY DIFFERENT REGIONS OF RUSSIA
by: N. B. Senyuta, et al.
Published: (2017-03-01) -
Sequence analysis of epstein-barr virus genomes in nasopharyngeal carcinoma
by: Kwok, Hin, et al.
Published: (2014) -
The evolution of Epstein-Barr virus detection in nasopharyngeal carcinoma
by: You Quan Li, et al.
Published: (2018-03-01)